Form 4: AIM ImmunoTech COO Peter Rodino III Acquires Shares in Open Market

Peter Rodino III, COO, Secretary, and General Counsel of AIM ImmunoTech Inc., purchased 37,879 shares of common stock at $0.33 per share on March 15, 2024.

Summary

• On March 15, 2024, Peter Rodino III, the COO, Secretary, and General Counsel of AIM ImmunoTech Inc., acquired 37,879 shares of common stock.
• The purchase price was $0.33 per share.
• Following the transaction, Rodino directly owns 181,718 shares of AIM ImmunoTech Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchasing shares can be seen as a positive sign, but it's a single transaction and doesn't provide definitive insight into the company's overall health.

Positives

• The purchase of shares by a company executive could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency into insider transactions and can be closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The purchase of shares by an executive could increase investor confidence.

Key Dates

Keywords

AIM ImmunoTech, Insider Trading, Form 4, Share Acquisition, Peter Rodino III, Common Stock